ICA-17043: Phase II data

In a 12-week, double-blind, placebo-controlled, dose-escalation, U.S. Phase II trial in 90

Read the full 122 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE